NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I do not know if they will or not, but I do not think they will arbitrarily withhold TLD either and the benefit any conference provides is access to media, not actually physical presence but the amplification that such a conference event provides as a platform for the industry generally. I actually do not think that is in fact diminished by the fact that all conferences will be virtual for the foreseeable future.

So I think if the announcement of imminent publication is appropriate, for any reason, an announcement will be released whenever it makes sense to do so. If then after that they are at a conference, whether it is virtual or not, there will be an opportunity to discuss it. But I would not get hung up on virtual conferences, one way or the other. I am not sure a lot is going to change for a while. I do not see them withholding data for the end of the pandemic.

If publication is delayed to July, then they may wait until closer to the publication date, but that will have little to do with whether ASCO was virtual or not, IMHO. As I said, almost everything had been virtualized for now and it is not clear when that will change fully into the foreseeable future. That can’t be a reason for delay, IMHO.